Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Selenium Test Predicts Prostate Cancer

By HospiMedica staff writers
Posted on 20 Apr 2006
A new noninvasive test designed to detect prostate cancer measures the selenium content of clippings from a toenail.

If a man has too little selenium, he can supplement his diet. More...
If he has too much selenium, he can stop taking selenium supplements. Supplementation with selenium, a trace mineral and an essential nutrient found in a variety of foods, can reduce oxidative stress and genetic damage in the prostate. However, too little selenium can lead to undesirably high levels of DNA damage within the prostate.

The SeleniumHealth test is available from Bostwick Laboratories, Inc. (Richmond, VA, USA), an international diagnostic pathology laboratory, under license from the Gerald P. Murphy Cancer Foundation (Lafayette, IN, USA).

"This new test enables men to take an active role in reducing their personal cancer risk by paying attention to how much selenium they consume,” said David G. Bostwick, M.D., CEO, and CMO of Bostwick Laboratories. "Every man should know his baseline level before taking selenium as too little or too much may do more harm than good.”

When the relationship between selenium intake and the amount of DNA damage that had accumulated in the prostate were investigated, researchers found that the amount of DNA damage was most severe at the lowest and highest selenium intake, noted David J. Waters, D.V.M., Ph.D., director of the Gerald P. Murphy Cancer Foundation. "Clearly, more was not always better.”



Related Links:
Bostwick Labs

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical System
Stealth AXiS
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.